Itching

Harrow has announced an exclusive out-licensing agreement with Apotex, a major Canadian pharmaceutical company, to market and distribute five of the company’s branded ophthalmic products.

The severity of chronic kidney disease-associated pruritus may be linked with higher risks of all-cause mortality, hospitalizations, cardiovascular events and infections, data show.

Patients with skin of color that suffer from scalp psoriasis saw significant improvement in their disease severity, scalp itch and quality of life outcomes when treated with Tremfya, according to newly released phase 3 results.

Prevalence of prurigo nodularis is higher than previously estimated and is associated with many comorbidities, according to a study.

A greater proportion of patients treated with nemolizumab for prurigo nodularis achieved an itch-free state than those treated with placebo, according to phase 3 results presented at the 25th World Congress of Dermatology.

Mirum Pharmaceuticals announced the European Commission has approved Livmarli for the treatment of cholestatic pruritis in patients with Alagille syndrome.

LOUISVILLE, Ky. — Dupilumab improved chronic spontaneous urticaria among patients whose disease did not respond to H1 antihistamines, according to a presentation here.

Clinics visits for itch and atopic dermatitis increased among adults aged 65 years and older during the California Camp Fire in 2018 compared with weeks without wildfire, according to a research letter published in JAMA Network Open.

Difelikefalin treatment reduced itching intensity among patients with chronic kidney disease-associated pruritus, according to data published in Kidney Medicine.

Patients with chronic spontaneous urticaria experience more pleasure from scratching itches compared with patients with other skin conditions, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.